Direct evidence for new T-cell generation by patients after either T-cell-depleted or unmodified allogeneic hematopoietic stem cell transplantations

被引:144
作者
Lewin, SR
Heller, G
Zhang, LQ
Rodrigues, E
Skulsky, E
van den Brink, MRM
Small, TN
Kernan, NA
O'Reilly, RJ
Ho, DD
Young, JW
机构
[1] Rockefeller Univ, Aaron Diamond AIDS Res Ctr, New York, NY 10021 USA
[2] Mem Sloan Kettering Canc Ctr, Dept Epidemiol & Biostat, New York, NY 10021 USA
[3] Mem Sloan Kettering Canc Ctr, Allogeneic Bone Marrow Transplantat Serv, New York, NY 10021 USA
[4] Mem Sloan Kettering Canc Ctr, Dept Pediat, New York, NY 10021 USA
[5] Mem Sloan Kettering Canc Ctr, Dept Med, New York, NY 10021 USA
关键词
D O I
10.1182/blood.V100.6.2235.h81802002235_2235_2242
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Successful allogeneic hematopoietic stem cell transplantation (HSCT) requires reconstitution of normal T-cell immunity. Recipient thymic activity, biologic features of the allograft, and preparative regimens all contribute to immune reconstitution. We evaluated circulating T-cell phenotypes and T-cell receptor rearrangement excision circles (TRECs) in 331 blood samples from 158 patients who had undergone allogeneic HSCTs. All Patients had received myeloablative conditioning regimens and were full donor chimeras in remission. Younger patients exhibited more rapid recovery and higher TRECs (P=.02). Recipients of T-cell-depleted allografts initially had lower TRECs than unmodified allograft recipients (P<.01), but the difference abated beyond 9 months. TREC level disparities did not achieve significance among adults with respect to type of allograft. Measurable, albeit low, TREC values correlated strongly with severe opportunistic infections (P<.01). This finding was most notable during the first 6 months after transplantation, when patients are at greatest risk but before cytofluorography can detect circulating CD45RA(+) T cells. Low TRECs also correlated strongly with extensive chronic graft-versus-host disease (P<.01). Recipients of all ages of either unmodified or T-cell-depleted allografts therefore actively generate new T cells. This generation is most notable among adult recipients of T-cell-depleted allografts, most of whom had also received antithymocyte globulin for rejection prophylaxis. Low TREC values are significantly associated with morbidity and mortality after transplantation. T-cell neogenesis, appropriate to age but delayed in adult recipients of T-cell depleted allografts, justifies interventions to hasten this process and to stimulate desirable cellular immune responses.
引用
收藏
页码:2235 / 2242
页数:8
相关论文
共 35 条
[31]   Lymphocyte reconstitution following non-myeloablative hematopoietic stem cell transplantation follows two patterns depending on age and donor/recipient chimerism [J].
Savage, WJ ;
Bleesing, JJH ;
Douek, D ;
Brown, MR ;
Linton, GM ;
Malech, HL ;
Horwitz, ME .
BONE MARROW TRANSPLANTATION, 2001, 28 (05) :463-471
[32]   Comparison of immune reconstitution after unrelated and related T-cell-depleted bone marrow transplantation: Effect of patient age and donor leukocyte infusions [J].
Small, TN ;
Papadopoulos, EB ;
Boulad, F ;
Black, P ;
Castro-Malaspina, H ;
Childs, BH ;
Collins, N ;
Gillio, A ;
George, D ;
Jakubowski, A ;
Heller, G ;
Fazzari, M ;
Kernan, N ;
MacKinnon, S ;
Szabolcs, P ;
Young, JW ;
O'Reilly, RJ .
BLOOD, 1999, 93 (02) :467-480
[33]  
SULLIVAN KM, 1991, SEMIN HEMATOL, V28, P250
[34]   Factors affecting thymic function after allogeneic hematopoietic stem cell transplantation [J].
Weinberg, K ;
Blazar, BR ;
Wagner, JE ;
Agura, E ;
Hill, BJ ;
Smogorzewska, M ;
Koup, RA ;
Betts, MR ;
Collins, RH ;
Douek, DC .
BLOOD, 2001, 97 (05) :1458-1466
[35]   Measuring recent thymic emigrants in blood of normal and HIV-1-infected individuals before and after effective therapy [J].
Zhang, LQ ;
Lewin, SR ;
Markowitz, M ;
Lin, HH ;
Skulsky, E ;
Karanicolas, R ;
He, YX ;
Jin, X ;
Tuttleton, S ;
Vesanen, M ;
Spiegel, H ;
Kost, R ;
van Lunzen, J ;
Stellbrink, HJ ;
Wolinsky, S ;
Borkowsky, W ;
Palumbo, P ;
Kostrikis, LG ;
Ho, DD .
JOURNAL OF EXPERIMENTAL MEDICINE, 1999, 190 (05) :725-732